Since no specific agonists of TRPV2 are commercially available, the contribution of TRPV2 in CBD evoked [Ca2+]i increase was verified by utilizing siRNA mediated knockdown of TRPV2 expression in cultured urothelial cells. The gene discussed is TRPV2; the disease is red-green color blindness.